2016 Communication Drug Development 
European Pharmaceutical Review
JUNE 24, 2022
The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. pocket expenses account for only seven percent of the overall cost of developing drugs.
Pharmaceutical Technology
NOVEMBER 30, 2022
A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. The evolution of CCIT. Time for change.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Putting Patients First Blog
APRIL 30, 2024
This method not only prioritizes the participant’s comprehension but also aligns with best practices in health communication that suggests a focused approach can significantly enhance understanding and retention of important information. The importance of using plain language in health communications is well-documented in literature.
pharmaphorum
SEPTEMBER 27, 2021
In addition, uncertainty is higher because historically some communities have shied away from using pharmaceutical products to treat their ailments – they have had their own cultural views on treatments and manufactured drugs have not necessarily been part of their lives. The same goes for filling quotas versus purposeful hiring.
pharmaphorum
APRIL 11, 2022
Delivering value for patients doesn’t start and end in our R&D labs; actions can be implemented across all stages of the drug development lifecycle to encourage and embrace a pro-innovation environment. Between 2016-2019, she was the medical affairs therapeutic area lead in haematology for Janssen Oncology across the EMEA region.
pharmaphorum
JUNE 25, 2021
But Dr Craig Granowitz, chief scientific officer of cardiology drug developer Amarin, says that this is only the tip of the iceberg when it comes to the devastating impact of CVD on global populations. “In That’s a huge communication challenge. The average UK patient only stays on their statins for a month.
Putting Patients First Blog
FEBRUARY 6, 2024
Nature Communications, 11(6265). The price of progress: funding and financing Alzheimer’s disease drug development. Translational Medicine Communications, 4(18). Progress in rare diseases research 2010-2016: an IRDiRC perspective. [link] 2 Aiyegbusi, O., Macpherson, K., Washington, J., Newsome, P., and Calvert, M.
Expert insights. Personalized for you.
105 
Let's personalize your content